3 Million Vaccine Doses Ready To Go Out Next Week: JHU's Sauer
Lauren Sauer, Johns Hopkins University Associate Professor of Emergency Medicine, on the latest news surrounding the coronavirus treatments, vaccines and spread. Barry Ritholtz, Founder of Ritholtz We...
11 Des 202026min
Mark Zuckerberg Always Knew What He Was Doing: Joe Nocera
Joe Nocera, Bloomberg Opinion columnist, discusses his column: "Facebook Has Only Itself to Blame for Drastic Remedy." Mandeep Singh, Senior Technology Analyst for Bloomberg Intelligence, discusses Ai...
10 Des 202027min
DoorDash Frenzy Shows Big Need For Retail Access to Pre-IPO Shares
Brianne Lynch, Head of Business Development & Partnerships at EquityZen, on the Airbnb and Doordash IPOs, and trading pre-IPO shares before they go public. Jim Vogel, Interest Rate Strategist for FHN ...
9 Des 202026min
'Astonishing' Astra Vaccine Reduces Asymptomatic Cases
Michelle Cortez, Health, Science and Medical Technology Reporter for Bloomberg, on AstraZeneca and Oxford's 'remarkable' covid-19 vaccine results. Dan Ives, Managing Director, Equity Research at Wedbu...
8 Des 202033min
Bill Dudley: Why Markets Should Worry About Inflation
Bill Dudley, former New York Fed President and senior researcher at Princeton University’s Center for Economic Policy Studies, discusses his column: "Five Reasons to Worry About Faster U.S. Inflation....
7 Des 202028min
U.S. Heading Towards A Second Contraction: BE's Riccadonna
Carl Riccadonna, Chief U.S. Economist for Bloomberg Economics, on the November jobs report and outlook for the economy. Christy Hill, Head of Americas Asset Management and Global Head of ESG, PGIM Rea...
4 Des 202031min
Covid Triggering Incredible Opportunities In Fallen Angels: Mellon
Paul Benson, Head of Fixed Income Efficient Beta at Mellon, a BNY Mellon Investment Management firm, discusses his outlook for the fallen angels’ universe. Victoria Espinel, CEO of BSA | The Software ...
3 Des 202029min
How The Ultra-Rich Are Investing After Biden Win: Tiger 21
Michael Sonnenfeldt, Chairman of TIGER 21, on how the ultra wealthy are investing under a Biden presidency. Sam Fazeli, Senior Pharmaceutical Analyst/Head of EMEA Research for Bloomberg Intelligence, ...
2 Des 202028min
